6 Differences in microbial etiology between hospital-acquired pneumonia and ventilator-associated pneumonia: a single-center retrospective study in Guang Zhou

7 Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study

8 Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum β-lactamases causing ventilator-associated pneumonia in China

9 Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China

10 An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines

11 Pseudomonas aeruginosa ventilator-associated pneumonia management

12 Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit

13 Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia

14 Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy

15 Differences in microbial etiology between hospital-acquired pneumonia and ventilator-associated pneumonia: a single-center retrospective study in Guang Zhou

16 Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study

17 Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum β-lactamases causing ventilator-associated pneumonia in China

18 Distribution and drug resistance of pathogenic bacteria in ventilator-associated pneumonia at a local hospital of North-eastern China

19 An antibiotic stewardship exercise in the ICU: building a treatment algorithm for the management of ventilator-associated pneumonia based on local epidemiology and the 2016 Infectious Diseases Society of America/American Thoracic Society guidelines

20 Pseudomonas aeruginosa ventilator-associated pneumonia management

21 Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit

22 Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia

23 Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy

24 Tracheal amylase: a cheap way to predict ventilator associated pneumonia in patients with traumatic brain injury.

25 Ventilatory Efficacy After Transcatheter Aortic Valve Replacement Predicts Mortality and Heart Failure Events in Elderly Patients.

26 Improving Mechanical Ventilator Clinical Decision Support Systems with a Machine Learning Classifier for Determining Ventilator Mode.

27 Comparison of ventilatory modes to facilitate liberation from mechanical ventilation: protocol for a systematic review and network meta-analysis.

28 Is gender inequity in ventilator management a "women's issue"?

29 A low oxygen consumption pneumatic ventilator for emergency construction during a respiratory failure pandemic.

30 Inhibitor of neuronal nitric oxide synthase improves gas exchange in ventilator-induced lung injury after pneumonectomy

31 Multicenter Experience with Neurally Adjusted Ventilatory Assist in Infants with Severe Bronchopulmonary Dysplasia.

32 Withdrawn: "Hypercapnia Attenuates Ventilator-induced Lung Injury through Vagus Nerve Activation" by Guang Li, Jiao Liu, Chen-Liang Zhou, Wen-Fang Xia and Di Zhang.

33 Clinical and Economic Consequences of Ventilator-Associated Pneumonia

34 A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)

35 ventilatory efficiency in children and adolescents: a systematic review

36 incidence of ventilator-associated pneumonia and impact of multidrug-resistant infections on patient's outcome: experience at an apex trauma centre in north india

37 assistência ventilatória domiciliar em crianças: descrição de um programa home ventilation of pediatric patients: description of a program

38 mechanisms of pentazocine-induced ventilatory depression and antinociception in anesthetized rats

39 pattern of bacteria and its susceptibility of ventilator-associated pneumonia patients in icu at dr. hasan sadikin general hospital, bandung

40 network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia

41 comparison of the therapeutic effects of bubble cpap and ventilator cpap on respiratory distress syndrome in premature neonates

42 influência da estratégia ventilatória no desempenho funcional de enxertos pulmonares em um modelo experimental de transplante pulmonar unilateral de doadores após parada cardiocirculatória ventilation strategy and its influence on the functional performance of lung grafts in an experimental model of single lung transplantation using non-heart-beating donors

43 commentary: central-acting therapeutics alleviate respiratory weakness caused by heart failure–induced ventilatory overdrive

44 looking under the bonnet of patient–ventilator asynchrony during noninvasive ventilation: does it add value?

45 association of compliance of ventilator bundle with incidence of ventilator-associated pneumonia and ventilator utilization among critical patients over 4 years

46 diagnosis of ventilator-associated pneumonia: where do we go from here?

47 impact of the international nosocomial infection control consortium (inicc)’s multidimensional approach on rates of ventilator-associated pneumonia in intensive care units in 22 hospitals of 14 cities of the kingdom of saudi arabia

48 ventilatory care in status asthmaticus

49 efeito do treinamento sobre a eficiência ventilatória de indivíduos saudáveis

50 preterm neonates with respiratory distress syndrome: ventilator-induced lung injury and oxidative stress

51 does amifostine reduce metabolic rate? effect of the drug on gas exchange and acute ventilatory hypoxic response in humans

52 comment on “differences in ventilatory threshold for exercise prescription in outpatient diabetic and sarcopenic obese subjects”

53 future directions and molecular basis of ventilator associated pneumonia

54 performance of icu ventilators during noninvasive ventilation with large leaks in a total face mask: a bench study

55 an unusual cause of ventilatory failure in motor neurone disease

56 non-exhaustive double effort test is reliable and estimates the first ventilatory threshold intensity in running exercise

57 lung-protective ventilation strategies for relief from ventilator-associated lung injury in patients undergoing craniotomy: a bicenter randomized, parallel, and controlled trial

58 investigation on risk factors of ventilator-associated pneumonia in acute cerebral hemorrhage patients in intensive care unit

59 superbugs causing ventilator associated pneumonia in a tertiary care hospital and the return of pre-antibiotic era!

60 aerossol bacteriano gerado por respiradores mecânicos: estudo comparativo bacterial aerosol generated by mechanical ventilators: a comparative study

61 comparison of respiratory and hemodynamic stability in patients with traumatic brain injury ventilated by two ventilator modes: pressure regulated volume control versus synchronized intermittent mechanical ventilation

62 aprv mode in ventilator induced lung injury (vili)

63 antibiotic utilization patterns in patients with ventilator-associated pneumonia: a canadian context

64 entendendo os mecanismos determinantes da lesão pulmonar induzida pela ventilação mecânica understanding the mechanisms of ventilator-induced lung injury

65 gambaran pengetahuan klinisi ruang rawat intensif mengenai ventilator associated pneumonia (vap) bundle di ruang rawat intensif rsup dr. hasan sadikin bandung

66 avaliação das modalidades ventilatórias no período transoperatório por meio de questionário evaluación de las modalidades ventilatorias en el período transoperatorio por medio de cuestionario evaluation of transoperatory ventilation modalities by a questionnaire

67 Hospital-Acquired Pneumonia, Health Care-Associated Pneumonia, Ventilator-Associated Pneumonia, and Ventilator-Associated Tracheobronchitis: Definitions and Challenges in Trial Design

68 Ventilator-Associated Pneumonia: The Clinical Pulmonary Infection Score as a Surrogate for Diagnostics and Outcome

69 Recommendations for Treatment of Hospital-Acquired and Ventilator-Associated Pneumonia: Review of Recent International Guidelines

70 Recommendations for Improving the Design, Conduct, and Analysis of Clinical Trials in Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

71 Review of Recent Clinical Trials of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Perspective from Academia

72 Use of Quantitative Cultures and Reduced Duration of Antibiotic Regimens for Patients with Ventilator-Associated Pneumonia to Decrease Resistance in the Intensive Care Unit

73 Other Therapeutic Modalities and Practices: Implications for Clinical Trials of Hospital-Acquired or Ventilator-Associated Pneumonia

74 Pharmacokinetic-Pharmacodynamic Considerations in the Design of Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Studies: Look before You Leap!

75 Use of Severity Scoring and Stratification Factors in Clinical Trials of Hospital-Acquired and Ventilator-Associated Pneumonia

76 Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator-Associated Pneumonia and Hospital-Acquired Pneumonia

77 A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

78 Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

79 End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration Perspective

80 The Argument against Using Quantitative Cultures in Clinical Trials and for the Management of Ventilator-Associated Pneumonia

81 Considerations Unique to Pediatrics for Clinical Trial Design in Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

82 Challenges in the Design and Conduct of Clinical Trials for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: An Industry Perspective

83 Quantitative Cultures for Diagnosing Ventilator-Associated Pneumonia: A Critique

84 Treatment Guidelines and Outcomes of Hospital-Acquired and Ventilator-Associated Pneumonia

85 Workshop on Issues in the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia

86 Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial

87 Diagnostic Techniques and Procedures for Establishing the Microbial Etiology of Ventilator-Associated Pneumonia for Clinical Trials: The Pros for Quantitative Cultures

88 Scenario 2: A Patient with Ventilator-Associated Bacterial Pneumonia—Introduction to Clinical Trial Design Issues

89 Untargeted Molecular Analysis of Exhaled Breath as a Diagnostic Test for Ventilator-Associated Lower Respiratory Tract Infections (BreathDx)

90 Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Keyword Connections

Journals

Research Groups

Bibliographies